ab sciex presentation · ab sciex presentation author: microsoft account created date: 7/1/2014...
TRANSCRIPT
Unlocking the Benefits of MicroLC with AB SCIEX and Eksigent Technology
Anthony Romanelli, Sr. Applications Manager
2 © 2014 AB SCIEX
What is Micro Flow LC?
0.5 mm
area = 18 area = 1area = 85
0.5 mm
area = 18 area = 1area = 85
HPLC using columns with inner diameter (ID) ≤ 1 mm
Typical Flow Rates: 5-200µL/min
Column diameter (mm) 0.3 0.5 1.0 2.1
Typical flow rate (mL/min) 10 35 140 600
3 © 2014 AB SCIEX
• Improve throughput
• Improve sensitivity (LOQ)
• Consume less sample
• Reduce LC and MS downtime
• Reduced costs
Why Use Micro LC?
4 © 2014 AB SCIEX
microLC 200plus System
• Microflow UHPLC (10,000 psi)
• System delay (void) volume: 1 – 3 µL
• Total system volume: ~ 4.5 µL
• Supports 1.0, 0.5, and 0.3 mm ID columns
• Flow rates 5 – 200 µL/min
• Programmable injection - from 15 nL
(metered) to 10 µL (without changing loop)
• Compact, Close coupling with MS source
- Small volume hybrid electrodes for Turbo VTM
and IonDrive™ Turbo V sources
Compact, high-throughput UHPLC system for LC/MS
5 © 2014 AB SCIEX
Electronically
Controlled
Pressure Source
Flow Meter
Control
Processor
Microfluidic Flow Control™ (MFC)
Microfluidic Flow Control Precise, stable flow for reproducible high-speed chromatography
• Proprietary Microfluidic Flow Control (MFC)
technology for rapid flow adjustment
• Continuous flow monitoring
• Operates up to 10,000 psi
• MFC and high pressure capability combine to
ensure precise and stable flow for reproducible,
high-speed chromatography
6 © 2014 AB SCIEX
MicroLC for Exenatide Quantitation
Assay Development Goals:
• Achieve sensitivity levels that enable
quantitation in plasma when slow release
exenatide is administered.
• Develop a selective, robust, and
reproducible method
• Demonstrate the ability to quantitate over a
wide dynamic range
QTRAP® 6500 System Nano LC400 System
IonDrive™ ion source microflow electrodes
7 © 2014 AB SCIEX
MicroLC for Exenatide Quantitation
Samples prepared by spiking standards into a crashed rat plasma matrix
8 © 2014 AB SCIEX
Stable Isotope Labeled Universal Monoclonal Antibody Standard
XIC chromatogram of signature peptide transitions in plasma matrix; SILUMab Standard in the insight
Heavy Chain DTLMISR
Heavy Chain FNWYVDGVEVHNAK
Heavy Chain VVSVLTVLHQDWLNGK
Light Chain YAASSYLSLTPEQWK
Light Chain AGVETTTPSK
9 © 2014 AB SCIEX
Quantitation of Signature Peptide AGEVETTPSK (light chain: +2y6 light)
• Excellent accuracy and precision over 4 orders of linear dynamic range
• Improved sensitivity compared to previous high flow data
• Over a 2 fold increase in throughput
LOQn=1
LOQn=2
LOQn=3
10 © 2014 AB SCIEX
J Proteome Res. 2014 Apr 4;13(4):1905-10
Peptide Quantitation with Micro Flow Publication
11 © 2014 AB SCIEX
MicroLC for Lipid Profiling
12 © 2014 AB SCIEX
MicroLC for Lipid Profiling - Chromatography
Improvement in chromatographic resolution with the microLC 200
13 © 2014 AB SCIEX
MicroLC for Lipid Profiling - Sensitivity
Significant gains
in sensitivity
achieved with
only 1/10th the
amount of
analyte loaded
on column
14 © 2014 AB SCIEX
MicroLC for Lipid Profiling - Reproducibility
Excellent reproducibility was achieved in regards to retention time,
chromatographic resolution, and signal intensity.
15 © 2014 AB SCIEX
Clin/Tox Robustness - Long Term Retention Time Stability
Retention time plot of quality control sample over 1000 injections in
pooled human urine
Guard column change (every ~250 injections)
16 © 2014 AB SCIEX
Pooled 8 Human Urine
10 ng/mL
Injection #20
1st Guard
Pooled 8 Human Urine
10 ng/mL
Injection #1000
4th Guard
Pooled 8 Human Urine
10 ng/mL
Injection #1001
No Guard
Clin/Tox Long Term Robustness – Column Performance and Peak Shape
Note: Micro flow method increased throughput ~2x
17 © 2014 AB SCIEX
• Improve throughput
• Improve sensitivity (LOQ)
• Consume less sample
• Reduce LC and MS downtime
• Reduced costs
Benefits of Micro LC with AB SCIEX and Eksigent Technology
18 © 2014 AB SCIEX
Trademarks/Licensing
• For Research Use Only. Not for use in diagnostic procedures.
• SCIEX and Eksigent are part of AB SCIEX. The trademarks
mentioned herein are the property of AB Sciex Pte. Ltd. or their
respective owners. AB SCIEX™ is being used under license.
• © 2014 AB SCIEX. All rights reserved. Information subject to change
without notice.
Questions and Answers
20 © 2013 AB SCIEX
AB SCIEX and Eksigent
What Can be Achieved When Technology Challenges Science